2025 年性行为感染传染病 (STD) 诊断全球市场报告

预计未来几年性行为感染传染病（STD）诊断的市场规模将快速成长。到 2029 年，这一数字将成长至 162.1 亿美元，复合年增长率为 10.5%。预测期内的成长可归因于个人化医疗的趋势、医疗保健服务的改善、人口健康策略、远端医疗和数位健康以及性行为感染传染病盛行率的上升。预测期内的关键趋势包括即时诊断、家庭检测套组、多重检测、有针对性的营销和推广、暴露前预防计划以及发病率的上升。

性行为感染传染病的流行是性行为感染传染病（STD）诊断市场向前发展的关键驱动因素。性病是透过性接触传播的感染疾病，是全球性的健康问题。 2022年，世界卫生组织（WHO）报告称，全球每天发生超过一百万例性行为感染传染病，包括披衣菌感染、淋病、梅毒和滴虫病，每年约有3.74亿新感染病例。性传染病发生率的不断上升凸显了性行为感染传染病（STD）诊断在有效分析和检测中的关键作用，从而推动了市场的成长。

预计未来几年医疗保健支出的增加将推动性行为感染传染病 (STD) 诊断市场的成长。医疗保健支出是指特定医疗保健系统或经济体在特定时期内用于医疗保健服务及相关商品和活动的总金额。这项医疗保健支出与性行为感染传染病 (STD) 诊断相关，因为它代表了对预防保健的策略性投资，解决了公共卫生优先事项，并有助于个人和社区层面的整体健康和福祉。例如，2024 年 5 月，英国政府机构国家统计局报告称，2022 年至 2023 年医疗保健总支出名义上将增长 5.6%，与 2022 年 0.9% 的增幅相比有显着增长。因此，医疗保健支出的增加正在推动性行为感染传染病 (STD) 诊断市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球性行为感染传染病 (STD) 诊断市场的 PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球性行为感染传染病 (STD) 诊断市场：成长率分析
• 全球性行为感染传染病 (STD) 诊断市场表现：规模与成长，2019-2024 年
• 全球性行为感染传染病 (STD) 诊断市场预测：规模与成长，2024-2029 年，2034 年
• 全球性行为感染传染病 (STD) 诊断总目标市场 (TAM)

第六章 市场细分

• 全球性行为感染传染病 (STD) 诊断市场类型、绩效及预测，2019-2024、2024-2029、2034
• 披衣菌感染检测
• 梅毒检测
• 淋病检查
• 单纯疱疹病毒检测
• 人类乳突病毒检测
• 人类免疫力缺乏 ( HIV ) 检测
• 软性下疳检查
• 其他的
• 全球性行为感染传染病 (STD) 诊断市场（按检测地点、表现和预测）2019-2024、2024-2029、2034
• 实验室测试
• 照护现场（PoC）测试
• 全球性行为感染传染病 (STD) 诊断市场（按最终用户、绩效和预测），2019-2024 年、2024-2029 年、2034 年
• 医院和诊所
• 诊断中心
• 居家护理
• 全球性行为感染传染病 (STD) 诊断市场：披衣菌感染检测细分类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 核酸增幅检查（NAAT）
• 抗原检测
• 全球性行为感染传染病 (STD) 诊断市场：梅毒检测细分类型、表现与预测，2019-2024 年、2024-2029 年、2034 年
• 快速血浆再生 (RPR) 检测
• 梅毒螺旋体检测
• 全球性行为感染传染病 (STD) 诊断市场：淋病检测细分类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 核酸增幅检查（NAAT）
• 文化
• 全球性行为感染传染病 (STD) 诊断市场：单纯疱疹病毒检测细分类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• PCR 检测
• 血清学检测
• 全球性行为感染传染病 (STD) 诊断市场：人类乳突病毒检测细分（按类型、效能和预测），2019-2024 年、2024-2029 年、2034 年
• HPV DNA 检测
• HPV RNA 检测
• 全球性行为感染传染病 (STD) 诊断市场：人类免疫力缺乏病毒检测按类型、效能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 抗体检测
• 抗原或抗体检测
• 核酸检测 (NAT)
• 全球性行为感染传染病 (STD) 诊断市场：软性下疳检测细分类型、效能和预测，2019-2024 年、2024-2029 年、2034 年
• 文化
• 核酸检测
• 全球性行为感染传染病 (STD) 诊断市场：按类型、实际和预测分類的其他细分市场，2019-2024 年、2024-2029 年、2034 年
• 各种新测试

第七章 区域和国家分析

• 全球性行为感染传染病 (STD) 诊断市场各地区、绩效及预测，2019-2024、2024-2029、2034
• 全球性行为感染传染病 (STD) 诊断市场（按国家/地区划分）、绩效及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 性行为感染传染病 (STD) 诊断市场：竞争格局
• 性行为感染传染病 (STD) 诊断市场：公司简介
  • Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Hologic Inc.
• Bio-Rad Laboratories Inc.
• Becton Dickinson and Company
• Thermo Fisher Scientific Inc.
• Biocartis NV
• Trinity Biotech PLC
• Binx Health Inc.
• NOWDiagnostics Inc.
• Atlas Genetics Ltd.
• BioFire Diagnostics LLC
• BioMerieux SA
• Chembio Diagnostic Systems Inc.
• Corgenix Medical Corporation
• Creative Diagnostics
• Curetis AG

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年性行为感染传染病 (STD) 诊断市场：提供新机会的国家
• 2029 年性行为感染传染病 (STD) 诊断市场：提供新机会的细分市场
• 性行为感染传染病 (STD) 诊断市场 2029：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Sexually Transmitted Diseases (STDs) diagnostics encompass the examination and identification of infectious conditions transmitted through sexual contact. These diagnostic procedures are essential in determining the presence of STDs within an individual.

The primary categories of STD diagnostics include chlamydia, syphilis, gonorrhea, herpes simplex virus, human papillomavirus, human immunodeficiency virus, chancroid, and other tests performed in laboratory and point-of-care settings. Chlamydia testing involves a urine sample analysis to detect infection. This specific test is employed for identifying chlamydia infections, a common bacterial sexually transmitted infection (STI) transmitted through various forms of sexual contact or genital exposure. These STD diagnostic procedures find application in hospitals, clinics, diagnostic centers, and homecare settings.

The STD diagnostics market research report is one of a series of new reports from The Business Research Company that provides STD diagnostics market statistics, including STD diagnostics industry global market size, regional shares, competitors with a STD diagnostics market share, detailed STD diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the STD diagnostics industry. This STD diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The STD diagnostics market size has grown strongly in recent years. It will grow from $9.93 billion in 2024 to $10.86 billion in 2025 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to epidemiological trends, healthcare infrastructure development, pharmaceutical developments, sexual education programs, demographic shifts.

The STD diagnostics market size is expected to see rapid growth in the next few years. It will grow to $16.21 billion in 2029 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to personalized medicine trends, healthcare access improvements, population health strategies, telemedicine and digital health, rising incidence of STDs. Major trends in the forecast period include point-of-care testing (POCT) advancements, home testing kits, multiplex testing, targeted marketing and outreach, pre-exposure prophylaxis (prep) programs, rising incidence rates.

The escalating prevalence of sexually transmitted diseases (STDs) is a significant driver propelling the STD diagnostics market forward. STDs, infectious diseases transmitted through sexual contact, have become a global health concern. In 2022, the World Health Organization reported that over 1 million sexually transmitted infections are acquired daily worldwide, with approximately 374 million new infections annually, including chlamydia, gonorrhea, syphilis, and trichomoniasis. The rising incidence of STDs underscores the critical role of STD diagnostics in efficient analysis and testing, driving the market's growth.

The increasing healthcare expenditure is anticipated to drive the growth of the STD diagnostics market in the future. Healthcare expenditure refers to the overall amount of money spent on healthcare services, related goods, and activities within a specific healthcare system or economy over a defined period. This expenditure is relevant to STD diagnostics as it signifies a strategic investment in preventive healthcare, addresses public health priorities, and contributes to overall health and well-being at both individual and community levels. For example, in May 2024, a report from the Office for National Statistics, a UK-based government department, indicated that total healthcare expenditure rose by 5.6% in nominal terms from 2022 to 2023, marking a significant increase compared to the 0.9% growth recorded in 2022. Thus, the rise in healthcare expenditures is fueling the growth of the STD diagnostics market.

The advancement of STD diagnostics is a significant trend within the STD diagnostic market. Major players are enhancing testing facilities and techniques to facilitate quicker and more accurate diagnoses of sexually transmitted diseases. For example, in May 2022, BD (Becton, Dickinson, and Company), a US-based medical technology firm, launched a fully automated, high-throughput molecular diagnostics platform for infectious diseases called the BD CORTM MX/PX System. This platform integrates and automates the molecular laboratory workflow, from sample processing to the delivery of diagnostic test results. The first test available on this new platform is the BD CTGCTV2 molecular assay, which is a single test capable of identifying the three most prevalent non-viral STIs (sexually transmitted infections): Chlamydia trachomatis (CT), Neisseria gonorrhoeae (GC), and Trichomonas vaginalis (TV).

Key companies in the STD diagnostics market are focusing on developing innovative products, such as real-time PCR kits, to meet unmet medical needs and improve diagnostic capabilities. A real-time PCR kit consists of a collection of reagents utilized for conducting real-time polymerase chain reaction (qPCR), a sensitive and commonly employed technique for detecting and quantifying specific nucleic acid sequences. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based research and development company, introduced the Mycoplasma Hominis Real Time PCR Kit and the Treponema Pallidum Real Time PCR Kit, specifically designed for detecting Mycoplasma hominis and Treponema pallidum. These kits offer high sensitivity and specificity, user-friendliness, rapid turnaround times, and the capability to detect multiple pathogens in a single test.

In February 2024, Thyrocare, an India-based healthcare company, acquired Think Health Care for an undisclosed amount. With this acquisition, Thyrocare aims to strategically enhance its service offerings and market reach, especially in the home healthcare segment. Think Health Care is an India-based company specializing in diagnostic and preventive healthcare, known for providing at-home ECG services.

Major companies operating in the STD diagnostics market are Siemens AG, Abbott Laboratories, Qiagen Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Hologic Inc., Bio-Rad Laboratories Inc., Becton Dickinson and Company, Thermo Fisher Scientific Inc., Biocartis NV, Trinity Biotech PLC, Binx Health Inc., NOWDiagnostics Inc., Atlas Genetics Ltd., BioFire Diagnostics LLC, BioMerieux SA, Chembio Diagnostic Systems Inc., Corgenix Medical Corporation, Creative Diagnostics, Curetis AG, Daktari Diagnostics, Enzo Biochem Inc., Fujirebio Diagnostics Inc., GenePOC Inc., GenMark Diagnostics Inc., Grifols Diagnostic Solutions Inc., Hain Lifescience GmbH, InDevR Inc., Karius Inc., Luminex Corporation, Meridian Bioscience Inc., Mesa Biotech Inc., Mobidiag Oy

North America was the largest region in the STD diagnostics market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the std diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the std diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The STD diagnostics market consists of revenues earned by entities by providing STD diagnostics tests such as cultural/isolated tests of organisms, molecular tests, and immunology assays. The market value includes the value of related goods sold by the service provider or included within the service offering. The STD diagnostics market also includes sales of thermal cyclers, PCR, lateral flow readers - immuno chromatographic assays, flow cytometers, differential light scattering machines, absorbance microplate readers, phone chips, and rapid diagnostic kits which are used in providing STD diagnostic services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

STD Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on std diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for std diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The std diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Chlamydia Testing; Syphilis Testing; Gonorrhea Testing; Herpes Simplex Virus Testing; Human Papilloma Virus Testing; Human Immunodeficiency Virus Testing; Chancroid Testing; Other Types
• 2) By Location Of Testing: Laboratory Testing; Point Of Care (PoC) Testing
• 3) By End-User: Hospitals And Clinics; Diagnostic Centers; Homecare
• Subsegments:
• 1) By Chlamydia Testing: Nucleic Acid Amplification Tests (NAAT); Antigen Tests
• 2) By Syphilis Testing: Rapid Plasma Reagin (RPR) Tests; Treponemal Tests
• 3) By Gonorrhea Testing: Nucleic Acid Amplification Tests (NAAT); Culture Tests
• 4) By Herpes Simplex Virus Testing: PCR Tests; Serological Tests
• 5) By Human Papilloma Virus Testing: HPV DNA Tests; HPV RNA Tests
• 6) By Human Immunodeficiency Virus Testing: Antibody Tests; Antigen Or Antibody Tests; Nucleic Acid Tests (NAT)
• 7) By Chancroid Testing: Culture Tests; Nucleic Acid Tests
• 8) By Other Types: Various Emerging Tests
• Companies Mentioned: Siemens AG; Abbott Laboratories; Qiagen Inc.; Danaher Corporation; F. Hoffmann-La Roche AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. STD Diagnostics Market Characteristics

3. STD Diagnostics Market Trends And Strategies

4. STD Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global STD Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global STD Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global STD Diagnostics Market Growth Rate Analysis
• 5.4. Global STD Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global STD Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global STD Diagnostics Total Addressable Market (TAM)

6. STD Diagnostics Market Segmentation

• 6.1. Global STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Chlamydia Testing
• Syphilis Testing
• Gonorrhea Testing
• Herpes Simplex Virus Testing
• Human Papilloma Virus Testing
• Human Immunodeficiency Virus Testing
• Chancroid Testing
• Other Types
• 6.2. Global STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Laboratory Testing
• Point Of Care (PoC) Testing
• 6.3. Global STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Diagnostic Centers
• Homecare
• 6.4. Global STD Diagnostics Market, Sub-Segmentation Of Chlamydia Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Amplification Tests (NAAT)
• Antigen Tests
• 6.5. Global STD Diagnostics Market, Sub-Segmentation Of Syphilis Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Rapid Plasma Reagin (RPR) Tests
• Treponemal Tests
• 6.6. Global STD Diagnostics Market, Sub-Segmentation Of Gonorrhea Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Nucleic Acid Amplification Tests (NAAT)
• Culture Tests
• 6.7. Global STD Diagnostics Market, Sub-Segmentation Of Herpes Simplex Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PCR Tests
• Serological Tests
• 6.8. Global STD Diagnostics Market, Sub-Segmentation Of Human Papilloma Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• HPV DNA Tests
• HPV RNA Tests
• 6.9. Global STD Diagnostics Market, Sub-Segmentation Of Human Immunodeficiency Virus Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibody Tests
• Antigen Or Antibody Tests
• Nucleic Acid Tests (NAT)
• 6.10. Global STD Diagnostics Market, Sub-Segmentation Of Chancroid Testing, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Culture Tests
• Nucleic Acid Tests
• 6.11. Global STD Diagnostics Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Various Emerging Tests

7. STD Diagnostics Market Regional And Country Analysis

• 7.1. Global STD Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global STD Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific STD Diagnostics Market

• 8.1. Asia-Pacific STD Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China STD Diagnostics Market

• 9.1. China STD Diagnostics Market Overview
• 9.2. China STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India STD Diagnostics Market

• 10.1. India STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan STD Diagnostics Market

• 11.1. Japan STD Diagnostics Market Overview
• 11.2. Japan STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia STD Diagnostics Market

• 12.1. Australia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia STD Diagnostics Market

• 13.1. Indonesia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea STD Diagnostics Market

• 14.1. South Korea STD Diagnostics Market Overview
• 14.2. South Korea STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe STD Diagnostics Market

• 15.1. Western Europe STD Diagnostics Market Overview
• 15.2. Western Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK STD Diagnostics Market

• 16.1. UK STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany STD Diagnostics Market

• 17.1. Germany STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France STD Diagnostics Market

• 18.1. France STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy STD Diagnostics Market

• 19.1. Italy STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain STD Diagnostics Market

• 20.1. Spain STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe STD Diagnostics Market

• 21.1. Eastern Europe STD Diagnostics Market Overview
• 21.2. Eastern Europe STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia STD Diagnostics Market

• 22.1. Russia STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America STD Diagnostics Market

• 23.1. North America STD Diagnostics Market Overview
• 23.2. North America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA STD Diagnostics Market

• 24.1. USA STD Diagnostics Market Overview
• 24.2. USA STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada STD Diagnostics Market

• 25.1. Canada STD Diagnostics Market Overview
• 25.2. Canada STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America STD Diagnostics Market

• 26.1. South America STD Diagnostics Market Overview
• 26.2. South America STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil STD Diagnostics Market

• 27.1. Brazil STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East STD Diagnostics Market

• 28.1. Middle East STD Diagnostics Market Overview
• 28.2. Middle East STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa STD Diagnostics Market

• 29.1. Africa STD Diagnostics Market Overview
• 29.2. Africa STD Diagnostics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa STD Diagnostics Market, Segmentation By Location Of Testing, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa STD Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. STD Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. STD Diagnostics Market Competitive Landscape
• 30.2. STD Diagnostics Market Company Profiles
  • 30.2.1. Siemens AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Qiagen Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. STD Diagnostics Market Other Major And Innovative Companies

• 31.1. Hologic Inc.
• 31.2. Bio-Rad Laboratories Inc.
• 31.3. Becton Dickinson and Company
• 31.4. Thermo Fisher Scientific Inc.
• 31.5. Biocartis NV
• 31.6. Trinity Biotech PLC
• 31.7. Binx Health Inc.
• 31.8. NOWDiagnostics Inc.
• 31.9. Atlas Genetics Ltd.
• 31.10. BioFire Diagnostics LLC
• 31.11. BioMerieux SA
• 31.12. Chembio Diagnostic Systems Inc.
• 31.13. Corgenix Medical Corporation
• 31.14. Creative Diagnostics
• 31.15. Curetis AG

32. Global STD Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The STD Diagnostics Market

34. Recent Developments In The STD Diagnostics Market

35. STD Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 STD Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 STD Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 STD Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer